Zhiping Cao Selected Research

Ischemia

1/2020	Ranolazine may exert its beneficial effects by increasing myocardial adenosine levels.
11/2008	Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
4/2005	Long-term infusion of Met5-enkephalin fails to protect murine hearts against ischemia-reperfusion injury.
4/2005	Met5-enkephalin-induced cardioprotection occurs via transactivation of EGFR and activation of PI3K.
9/2003	Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiping Cao Research Topics

Disease

5	Ischemia 01/2020 - 09/2003
4	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 04/2005
2	Neoplasms (Cancer) 01/2023 - 02/2016
2	Reperfusion Injury 01/2018 - 11/2008
1	Brain Infarction 01/2023
1	Hyperthermia 01/2023
1	Starvation 01/2023
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2023
1	Stroke (Strokes) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	No-Reflow Phenomenon 12/2021
1	Myocardial Infarction 12/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2020
1	Angina Pectoris 01/2020
1	Hypoxia (Hypoxemia) 01/2008
1	Infarction (Infarctions) 04/2005

Drug/Important Bio-Agent (IBA)

2	Collagenases (Collagenase)FDA Link 01/2008 - 04/2005
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Hydroxyl RadicalIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	EicosanoidsIBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Ranolazine FDA Link 01/2020
1	Dobutamine FDA LinkGeneric 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2016
1	AmidophosphoribosyltransferaseIBA 02/2016
1	EstersIBA 11/2008
1	12-(3-adamantan-1-ylureido)dodecanoic acid butyl esterIBA 11/2008
1	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 11/2008
1	Arachidonic Acid (Vitamin F)IBA 11/2008
1	AcidsIBA 11/2008
1	Epoxide HydrolasesIBA 11/2008
1	Peptides (Polypeptides)IBA 04/2005
1	Methionine EnkephalinIBA 04/2005
1	Propidium (Propidium Iodide)IBA 04/2005
1	barbituric acid (barbiturate)IBA 04/2005
1	Opioid Peptides (Opioid Peptide)IBA 09/2003

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Immunotherapy 01/2023
1	Phototherapy (Light Therapy) 01/2023
1	Radiotherapy 01/2023
1	Aftercare (After-Treatment) 12/2021